1. Persistent Fetal SVT in a COVID-19 Positive Pregnancy
- Author
-
Gloria Wang, Eric Stapley, Sara Peterson, Jessica Parrott, and Cecily Clark-Ganheart
- Subjects
Gynecology and obstetrics ,RG1-991 - Abstract
Background. Rapid introduction and spread of SARS-CoV-2 have posed unique challenges in understanding the disease, role in vertical transmission, and in developing management. We present a case of a patient with COVID-19 infection and fetus with new-onset fetal SVT. Case. A 26-year-old gravida 4 para 2012 with third trimester COVID-19 infection was diagnosed with new onset fetal SVT. Successful cardioversion was achieved with flecainide. The patient was followed outpatient until induction of labor at 39 and 3/7 weeks of gestational age resulting in an uncomplicated vaginal delivery. Postpartum course was uncomplicated. Conclusion. Fetal SVT is a potential complication of maternal COVID-19 infection. The use of transplacental therapy with flecainide is an appropriate alternative to digoxin in these cases.
- Published
- 2022
- Full Text
- View/download PDF